author-photo

Christian Gessner

Leipzig University

120

Papers

1415

Citations

Citation Trend

Filter By

Papers (81) Sort By

Journal Conference Others

Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma

2021 Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study

2021 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European Studies.

2021 Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program

2021 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (0)
Mometasone/indacaterol demonstrates similar efficacy in men and women: pooled analyses of PALLADIUM and IRIDIUM studies

2021 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (0)
News: Immuntherapiekombis palliativ und TKI als Adjuvans bei EGFR-NSCLC

2020
- Stefan Hammerschmidt
- Christian Gessner
Show All
- Source
- Cite
- Save
Citations (0)
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study

2020 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (17)
Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)" [Respir. Med. 170 (Aug-Sep 2020) 106021].

2020 Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (5)
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study

2019 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (103)
High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids

2016 BMC Pulmonary Medicine
Show All
- Source
- Cite
- Save
Citations (5)